SCHEMBL4537384

SCHEMBL4537384

O=C(NCC1CCN(S(=O)(=O)c2ccc(Cl)cc2Cl)C1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.45
DRD2 P14416 2/20 0.42
DRD4 P21917 2/20 0.42
ACLY P53396 1/20 0.42
EPHX2 P34913 3/20 0.42
USP30 Q70CQ3 1/20 0.41
TRPV4 Q9HBA0 2/20 0.40
ALDH1A1 P00352 1/20 0.40
SLC13A5 Q86YT5 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4537312 0.95 P2RX7 (0.43) P2RX7DRD2DRD4USP30ALDH1A1
SCHEMBL4537036 0.95 P2RX7 (0.47) P2RX7DRD2DRD4EPHX2TRPV4
SCHEMBL8060983 0.95 P2RX7 (0.47) P2RX7DRD2DRD4EPHX2TRPV4
SCHEMBL4539753 0.88 HDAC3 (0.49) P2RX7ACLYEPHX2ALDH1A1
SCHEMBL4535935 0.87 EPHX2 (0.52) EPHX2
SCHEMBL8061563 0.86 LMNA (0.51) DRD2DRD4EPHX2ALDH1A1SLC13A5
SCHEMBL4535269 0.86 LMNA (0.51) DRD2DRD4EPHX2ALDH1A1SLC13A5
SCHEMBL4535853 0.84 FBP1 (0.46) ALDH1A1SLC13A5MEN1KMT2A
SCHEMBL4538127 0.83 CCR1 (0.46) P2RX7EPHX2
SCHEMBL8049830 0.83 HSD11B1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070497-A1 SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-06-04 WO claimed
WO-2009070497-A1 SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-06-04 WO disclosed
WO-2009070497-A1 SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-06-04 WO disclosed